PHEBRA

Pharmaceutical preparations for the treatment of pain, cancer, infectious diseases, gastrointestinal diseases and conditions, skin conditions, respiratory conditions, neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, medicines for the treatment of cancer, epilepsy and manic, depressive and psychotic states; medicinal preparations, namely, medicines for the treatment of cancer, epilepsy and manic, depressive and psychotic states; vitamin preparations; electrolyte solutions for medical use, namely, electrolyte replacement solutions; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable solutions for medical purposes, namely, sterile injectable dyes for in vivo human medical diagnostic procedures